Carcinosarcoma of the ovary in a patient with a germline BRCA2 mutation: Evidence for monoclonal origin

Gynecologic Oncology

Volumn 76, Issue 2, 2000, Pages 226-229

  Sonoda, Yukio ^a   Saigo, Patricia E ^a   Federici, Mark G ^a   Boyd, Jeff ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALLELE; ARTICLE; CARCINOSARCOMA; CASE REPORT; CHROMOSOME MICRODISSECTION; FEMALE; GENE MUTATION; HUMAN; ONCOGENE; OVARY CARCINOMA; PRIORITY JOURNAL; STEM CELL;

EID: 0033978817     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5681     Document Type: Article

References (16)

1. Ford D, Easton D F, Bishop D T, Narod S A, Goldgar D E. Risks of cancer in BRCA1 mutation carriers. Lancet. 343:1994;692-695.
2. J Natl Cancer Inst. 91:1999;1310-1316.
3. Rubin S C, Benjamin I, Behbakht K, Takahashi H, Morgan M A, LiVolsi V A, Berchuck A, Muto M G, Garber J E, Weber B L, Lynch H T, Boyd J. Clinical and pathologic features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med. 335:1996;1413-1416.
4. Boyd J, Sonoda Y, Federici M G, Bogomolniy F, Rhei E, Maresco D L, Barakat R R, Brown C L, Chi D S, Curtin J P, Poynor E A, Hoskins W J. Clinical and pathologic features of hereditary ovarian cancers associated with germline mutations in BRCA1 or BRCA2. Gynecol Oncol. 72:1999;444.
5. Russell P. Surface epithelial-stromal tumors of the ovary. Kurman R J. Blaustein's Pathology of the Female Genital Tract. 1994;705-782 Springer-Verlag, New York.
6. Takeda A, Matsuyama M, Kuzuya K, Chihara T, Tsubouchi S, Takeuchi S. Mixed mesodermal tumor of the ovary with carcinoembryonic antigen and alkaline phosphatase production. Histochemical, autoradiographic, and electron microscopic studies of heterotransplanted tumors in athymic nude mice. Cancer. 53:1984;103-112.
7. Masuda A, Takeda A, Fukami H, Yamada C, Matsuyama M. Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary. Carcinomatous cells are changeable to sarcomatous cells. Cancer. 60:1987;2696-2703.
8. Wada H, Enomoto T, Fujita M, Yoshino K, Nakashima R, Kurachi H, Haba T, Wakasa K, Shroyer K R, Tsujimoto M, Hongyo T, Nomura T, Murata Y. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res. 57:1997;5379-5385.
9. Rhei E, Bogomolniy F, Federici M G, Maresco D L, Offit K, Robson M E, Saigo P E, Boyd J. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers. Cancer Res. 58:1998;3193-3196.
10. Oddoux C, Struewing J P, Clayton C M, Neuhausen S, Brody L C, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet. 14:1996;188-190.
11. Roa B B, Boyd A A, Volcik K, Richards C S. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet. 14:1996;185-187.
12. Van der Heijden O, Chiu H-C, Park T-C, Takahashi H, LiVolsi V A, Risinger J I, Barrett J C, Berchuck A, Evans A C, Behbakht K, Menzin A W, Liu P C, Benjamin I, Morgan M A, King S A, Rubin S C, Boyd J. Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosom 7q. Mol Carcinog. 23:1998;243-247.
13. Collins N, McManus R, Wooster R, Mangion J, Seal S, Lakhani S R, Ormiston W, Daly P A, Ford D, Easton D F, Stratton M R. Consistent loss of the wild-type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene. 10:1995;1673-1675.
14. Gudmundsson J, Johannesdottir G, Bergthorsson J T, Arason A, Ingvarsson S, Egilsson V, Barkardottir R B. Different tumor types from BRCA2 mutation carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res. 55:1995;4830-4832.
15. Johannsson O, Ostermeyer E A, Hakansson S, Friedman L S, Johansson U, Sellberg G, Brondum-Nielsen K, Sele V, Olsson H, King M-C, Borg A. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet. 58:1996;441-450.
16. Auersperg N, Edelson M I, Mok S C, Johnson S W, Hamilton T C. The biology of ovarian cancer. Semin Oncol. 25:1998;281-304.